2025
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
Ramachandran D, Wang X, Laisk T, Zheng Y, Ingold N, Canson D, Kho P, Naumann B, Chapman C, Bousset K, Krause A, Schürmann P, Wieland B, Hanel P, Hülse F, Häfner N, Runnebaum I, Dubrowinskaja N, Turmanov N, Yugay T, Yessimsiitova Z, Amant F, Annibali D, Beckmann M, Bodelon C, Buchanan D, Chen C, Clarke M, Cook L, De Vivo I, De Wispelaere W, Du M, Easton D, Emons J, Fasching P, Friedenreich C, Gallagher G, Giles G, Goode E, Harris H, Hunter D, Kolin D, Kraft P, Lacey J, Lambrechts D, Lu L, Mutter G, Naduparambil J, O’Connell K, Patel A, Pharoah P, Rebbeck T, Ricceri F, Risch H, Ruebner M, Sacerdote C, Scott R, Setiawan V, Shu X, Southey M, Tham E, Tomlinson I, Turman C, Wentzensen N, Xu W, Yu H, Zheng W, Spurdle A, Yarden Y, Team E, Mägi R, Hillemanns P, Glubb D, Dörk T, O’Mara T. GWAS meta-analysis identifies five susceptibility loci for endometrial cancer. EBioMedicine 2025, 118: 105830. PMID: 40633141, PMCID: PMC12275056, DOI: 10.1016/j.ebiom.2025.105830.Peer-Reviewed Original ResearchConceptsGenome-wide association studiesGenome-wide association study meta-analysisRisk lociGenome-wide association study analysisGenome-wide significant risk lociTumor suppressorNeuron navigator 3Significant risk lociGene-based analysisEndometrial Cancer Association ConsortiumSignificant lociValidation genotypingAssociation studiesSusceptibility lociMeta-analysisEndometrial cancer casesCell divisionHigh-income countriesLociEnvironmental risk factorsCell deathCell survivalEndometrial cancerNAV3Case-control series
2011
LIN28B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer
Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Ge W, Gentry-Maharaj A, Gonzalez-Bosquet J, Goode EL, Iversen E, Jim H, Kong W, McLaughlin J, Menon U, Monteiro AN, Narod SA, Pharoah PD, Phelan CM, Qu X, Ramus SJ, Risch H, Schildkraut JM, Song H, Stockwell H, Sutphen R, Terry KL, Tyrer J, Vierkant RA, Wentzensen N, Lancaster JM, Cheng JQ, Sellers TA, Consortium O. LIN28B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer. Cancer Research 2011, 71: 3896-3903. PMID: 21482675, PMCID: PMC3107389, DOI: 10.1158/0008-5472.can-10-4167.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAllelesCarcinoma, Ovarian EpithelialCase-Control StudiesCell Line, TumorDNA-Binding ProteinsDNA, NeoplasmFemaleGenetic Predisposition to DiseaseHumansMicroRNAsMiddle AgedNeoplasms, Glandular and EpithelialOvarian NeoplasmsPolymorphism, Single NucleotideRNA-Binding ProteinsTransfectionConceptsMiRNA biogenesis genesSingle nucleotide polymorphismsBiogenesis genesPutative transcription factorLuciferase reporter assaysMicroRNA biogenesisTranscription factorsPromoter regionTumor suppressorReporter assaysQuantitative RT-PCREOC susceptibilityGenesNucleotide polymorphismsLIN28B overexpressionLIN28B expressionLIN28B geneInfluence susceptibilityRT-PCRExpressionEpithelial ovarian cancerBiogenesisDroshaOvarian cancerFMR1
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply